Trial Profile
A real world, retrospective study assessing persistence and adherence in patients with Parkinson's disease treated with Amantadine immediate release
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2017
Price :
$35
*
At a glance
- Drugs Amantadine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 24 May 2017 Results presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 23 May 2017 New trial record